Clinical Trial Update: Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

View source ↗

Summary

This clinical trial update evaluates the benefit of direct-acting antiviral therapy in patients with chronic hepatitis C, including HIV coinfection and mixed cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Mixed Cryoglobulinemia

Drugs mentioned

• Direct-acting antivirals (DAAs)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatitis C, Chronic, Mixed Cryoglobulinemia | Status: COMPLETED